(Q70315525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

The first clinical use of depot buserelin for advanced prostatic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

6

G M Besser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

J H Waxman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J Sandow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

A Man

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

M J Barnett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

W F Hendry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

R T Oliver

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

P J Magill

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

174-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

10 October 2019

cites work

1 reference

12 December 2020

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

1 reference

12 December 2020

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

1 reference

12 December 2020

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone

1 reference

12 December 2020

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer

1 reference

12 December 2020

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00262291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3098445%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference